Hiral Labs Ltd.

Hiral Labs Ltd. is a pharmaceutical formulation company committed to the wellbeing of everyone. Established in October 2000, the company is engaged in the manufacturing and marketing of finished pharmaceutical products. Hiral Labs holds accreditation from WHO: GMP and ISO 9001:2008, reflecting its commitment to quality and standards compliance.

Within the domestic market, Hiral Labs offers over 200 brand formulations to prescribing physicians and hospitals, with more than 80 distributors marketing these products through its two marketing divisions - Hiral Labs Ltd. & Sahet India. Moreover, the company also manufactures approximately 500 formulations on a contractual basis for over 285 companies, encompassing around 4000 brands.

Extending its reach globally, Hiral Labs exports its products to several countries including Philippines, Cambodia, Sri Lanka, Canada, Romania, Yemen, UAE, Iraq, Tunisia, Ivory Coast, and Kenya. The company also has overseas associated companies such as RAALI HEALTH INC., Canada and MAPS PHARMA Pvt. Ltd. in Sri Lanka, enhancing its global marketing and distribution presence.

Hiral Labs' success is attributed to its steadfast commitment to quality drugs, timely supplies, and transparent dealings. With its established presence in the pharmaceutical industry and focus on global expansion, Hiral Labs presents a compelling opportunity for investors seeking to align with a company dedicated to providing quality healthcare solutions.